Celebrex and Poisoning - a phase IV clinical study of FDA data

Summary:

Poisoning is reported as a side effect among people who take Celebrex (celecoxib), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Tylenol, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Poisoning when taking Celebrex. It is created by eHealthMe based on reports of 147,540 people who have side effects when taking Celebrex from the FDA, and is updated regularly.

What is Celebrex?

Celebrex has active ingredients of celecoxib. It is often used in arthritis. eHealthMe is studying from 151,105 Celebrex users. Check the latest studies of Celebrex.

What is Poisoning?

Poisoning is found to be associated with 462 drugs and 637 conditions by eHealthMe. Check the latest studies of Poisoning.

On Aug, 02, 2026

147,540 people reported to have side effects when taking Celebrex.
Among them, 38 people (0.03%) have Poisoning.

Among these 38 people:

How long have people been on Celebrex when they have Poisoning? *

What is the gender of people who have Poisoning when taking Celebrex? *

female: 75.68 %
male: 24.32 %

What is the age of people who have Poisoning when taking Celebrex? *

What are other drugs people take besides Celebrex? *

Tylenol: 7 people, 18.42%
Bextra: 5 people, 13.16%
Zanaflex: 4 people, 10.53%
Alprazolam: 4 people, 10.53%
Prednisone: 4 people, 10.53%
Synthroid: 4 people, 10.53%
Sulfasalazine: 3 people, 7.89%
Hydroxychloroquine Sulfate: 3 people, 7.89%
Flexeril: 3 people, 7.89%
Remicade: 3 people, 7.89%

What are other side effects people have besides Poisoning? *

Malaise (a feeling of general discomfort or uneasiness): 9 people, 23.68%
Headache (pain in head): 8 people, 21.05%
Nausea (feeling of having an urge to vomit): 7 people, 18.42%
Fever: 6 people, 15.79%
Joint Pain: 6 people, 15.79%
Musculoskeletal Stiffness (stiffness of the body's muscles, joints, tendons, ligaments and nerves): 6 people, 15.79%
Dizziness: 6 people, 15.79%
Urinary Tract Infection: 6 people, 15.79%
Gastroenteritis (inflammation of stomach and intestine): 6 people, 15.79%
Nausea And Vomiting: 5 people, 13.16%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 7 people, 18.42%
Ill-Defined Disorder: 5 people, 13.16%
Intervertebral Disc Protrusion (spinal disc protrusion): 4 people, 10.53%
High Blood Pressure: 3 people, 7.89%
Juvenile Rheumatoid Arthritis (joint inflammation in children due to systemic disease): 3 people, 7.89%
Thyroid Diseases: 2 people, 5.26%
Autoimmune Disorder (a condition in which the immune system attacks the body's normal substances and tissue): 2 people, 5.26%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 2 people, 5.26%
Osteoporosis (bones weak and more likely to break): 2 people, 5.26%
Inflammation: 2 people, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Celebrex and have Poisoning?

- Check whether Poisoning is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Celebrex:

Celebrex (151,105 reports)

Poisoning treatments and more:

Poisoning (13,050 reports)

Browse all side effects of Celebrex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Poisoning:

Poisoning (462 drugs)

Browse all the conditions that are associated with Poisoning:

Poisoning (637 conditions)

Related publications that referenced our studies

Liaw GW, Hung DZ, Chen WK, Lin CL, Lin IC, Kao CH, "Relationship Between Acute Benzodiazepine Poisoning and Acute Pancreatitis Risk: A Population-Based Cohort Study", Medicine, 2015 Jan .
Liaw GW, Hung DZ, Chen WK, Lin CL, Lin IC, Kao CH, "Relationship Between Acute Benzodiazepine Poisoning and Acute Pancreatitis Risk: A Population-Based Cohort Study", Medicine, 2015 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on celecoxib (the active ingredients of Celebrex) and Celebrex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.